2002
Joao Delgado, M.D.
Rocky Mountain Poison and Drug Center
Role of Oxidative Stress in Contrast-Induced Nephropathy
2003
Dr. Christopher DeWitt
Rocky Mountain Poison and Drug Information, Denver, CO
The Effect of Amiodarone Pretreatment on Survival of Mice with Cocaine Toxicity
Resultant Publication:
DeWitt C, Cleveland NJ, Dart RC, Heard K. The effect of amiodarone pretreatment on survival of mice with acute cocaine toxicity. J Med Toxicol. 2005;1:11-18.
2004
Brandon Wills, D.O.
Toxicon Consortium, Cook County Hospital Chicago, IL
The Effect of Amifostine, a Cytoprotective Agent, on Paraquat Toxicity in Mice
Resultant Publication:
The Effect of Amifostine, a Cytoprotective Agent, on Paraquat Toxicity in Mice. Journal of Medical Toxicology, Vol. 3, No. 1, 2007; 1-6.
2005
Melissa Lai, M.D.
Harvard Medical Toxicology Fellowship at Children's Hospital Boston and Beth Israel Deaconesss Medical Center, Boston, MA
A Methodology for Creating a Web-Based Database of Hospital Antidote Par Levels for Local Disaster Triage Prior to Push-Pack Delivery
Poster presented at the North American Congress of Clinical Toxicology (NACCT), Orlando, FL, September 2005.
2006
Michael Ganetsky, M.D.
Univ. of Massachusetts Medical Center
Exploratory double-blind crossover trial of cyproheptadine as a treatment for lithium-induced tremor
2007
Steve Salhanick, M.D.
Beth Israel Hospital, Boston MA
Administration of UDP-glucuronosyl transferase co-substrates uridine 5’ diphosphoglucose and/or uridine 5’ diphosphoglucuronic acid to increase clearance and reduce toxicity of acetaminophen
2008
Mark Yarema, M.D.
Calgary Health Region
Deaths in patients hospitalized for acetaminophen poisoning in Canada from 1980-2005
2009
Stephanie Hernandez, M.D.
New York University School of Medicine
The Extracorporeal Removal (ECR) on N-acetylcysteine (NAC)
2010
Andrew Stolbach, M.D.
John Hopkins University
Identify Type and Frequency of CYP2E1 Polymorphisms in Patients with Acetaminophen Hepatotoxicity
1999
Richard Wang
2000
Richard Dart, M.D.
Greg Bogdan, PhD
2001
Lawrence Quang, M.D.
2002
David Barry, M.D.
University of California, San Diego
Vasopressin Treatment of Verapamil Toxicity in a Porcine Model
2003
Jason Chu, M.D.
St. Lukes – Roosevelt Hospital Center
The Effects of Escalating Doses of Glibenclamide in Severe Verapamil Toxicity
2004
William Meggs, M.D., PhD
Eastern Carolina University
Neurotoxicity of Chronic Exposure to Low Levels of Organophosphate Insecticides and Antidotal Therapy
Resultant Publication:
Weight gain associated with chronic exposure to chlorpyrifos in rats. Journal of Medical Toxicology, Vol. 3, No. 3, 2007; 89-93.
2005
Steven Bird, M.D.
University of Massachusetts Medical Center
Organophosphorus hydrolase for acute parathion poisoning
Resultant Publication:
OpdA, a bacterial organophosphorus hydrolase, prevents lethality in rats after poisoning with highly toxic organophosphorus pesticides, Toxicology. 2008 May 21: 247(2-3): 88-92.
2006
Andis Graudins, MB BS (Hons), PhD
Prince of Wales Hospital, Randwick, NSW, Australia
University of New South Wales, Kensington, NSW, Australia
Treatment of experimental heart failure resulting from verapamil poisoning with levosimendan
Resultant Publication:
Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity. Clin Toxicol (Phila). 2008 Jan; 46(1): 50-6.
2007
Dr. Kenneth Katz and Dr. Michael Lynch
University of Pittsburgh Medical Center
Survival of verapamil-poisoned pigs treated with thyroxine
Resultant Publication:
Survival of verapamil-poisoned rats treated with triiodothyronine. Journal of Medical Toxicology, Vol. 6, No. 2, 2010; 94-9.